Please enable JavaScript to continue using this application.

Compare $IMUX vs $VXRT | Chartloom

Compare

$IMUX vs $VXRT

Immunic Inc · Vaxart Inc

IMUX

Immunic Inc

VXRT

Vaxart Inc

Compare $IMUX vs $VXRT

Comparing Immunic Inc and Vaxart Inc

IMUXImmunic Inc

VXRTVaxart Inc

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

VXRTVaxart Inc

Market cap

$105M

P/E (TTM)

2.73x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

201.1%

YTD performance

19.2%

52W performance

26.5%

FCF yield

31.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUX

VXRT

Detailed metrics comparison

IMUX

Immunic Inc

VXRT

Vaxart Inc

Market Cap

IMUX$112M

VXRT$105M

Enterprise Value

IMUX$-44M

VXRT$62M

Price

IMUX$8.19

VXRT$0.43

P/E Ratio

IMUXN/A

VXRT2.73x

P/S Ratio

IMUX0.00x

VXRT0.43x

EV/Sales

IMUX0.00x

VXRT0.25x

EV/EBITDA

IMUX0.00x

VXRT1.01x

P/B Ratio

IMUX0.85x

VXRT1.27x

P/FCF Ratio

IMUXN/A

VXRT3.15x

EV/FCF

IMUX0.49x

VXRT1.85x

PEG Ratio

IMUXN/A

VXRTN/A

Forward P/E (NTM)

IMUXN/A

VXRTN/A

Forward P/S (NTM)

IMUXN/A

VXRTN/A

Revenue (TTM)

IMUX$0

VXRT$243M

Revenue Growth (YoY)

IMUXN/A

VXRT201.1%

Forward Rev Growth

IMUX650.4%

VXRT-98.8%

Gross Margin (TTM)

IMUX0.0%

VXRT100.0%

Operating Margin (TTM)

IMUX0.0%

VXRT16.3%

EBITDA Margin (TTM)

IMUX0.0%

VXRT18.8%

Net Margin (TTM)

IMUX0.0%

VXRT15.9%

FCF Margin (TTM)

IMUXN/A

VXRT13.7%

Net Income (TTM)

IMUX$-112M

VXRT$39M

FCF (TTM)

IMUX$-88M

VXRT$33M

EPS (TTM)

IMUX-$2.62

VXRT$0.16

ROE (TTM)

IMUX-9567.0%

VXRT53.0%

ROA (TTM)

IMUX-10788.0%

VXRT20.8%

ROIC (TTM)

IMUX-9567.0%

VXRT50.2%

Cash

IMUX$155M

VXRT$48M

Debt

IMUX$0

VXRT$5M

Net Cash/Debt

IMUX$155M

VXRT$43M

Current Ratio (TTM)

IMUX5.05x

VXRT1.60x

Quick Ratio (TTM)

IMUX5.00x

VXRT1.52x

Debt/Equity (TTM)

IMUX0.00x

VXRT0.06x

Debt/Assets (TTM)

IMUX0.0%

VXRT0.0%

Interest Coverage (TTM)

IMUXN/A

VXRTN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

VXRT0.00x

Beta

IMUX1.47

VXRT1.23

52W Performance

IMUX-8.8%

VXRT26.5%

YTD Performance

IMUX40.5%

VXRT19.2%

% from 52W High

IMUX-53.0%

VXRT-48.6%

% from 52W Low

IMUX61.9%

VXRT42.4%

Asset Turnover (TTM)

IMUX0.00x

VXRT1.31x

FCF Yield (TTM)

IMUX-78.9%

VXRT31.8%

Earnings Yield (TTM)

IMUX-100.0%

VXRT36.7%

Dividend Yield (TTM)

IMUXN/A

VXRTN/A

Rule of 40

IMUX0.0

VXRT214.8

EV/GP/RG

IMUXN/A

VXRTN/A

Ticker research

View IMUX research View VXRT research

Metric	IMUX Immunic Inc	VXRT Vaxart Inc
Market & Valuation
Market Cap	$112M	$105M
Enterprise Value	$-44M	$62M
Price	$8.19	$0.43
P/E Ratio	N/A	2.73x
P/S Ratio	0.00x	0.43x
EV/Sales	0.00x	0.25x
EV/EBITDA	0.00x	1.01x
P/B Ratio	0.85x	1.27x
P/FCF Ratio	N/A	3.15x
EV/FCF	0.49x	1.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$243M
Revenue Growth (YoY)	N/A	201.1%
Forward Rev Growth	650.4%	-98.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	16.3%
EBITDA Margin (TTM)	0.0%	18.8%
Net Margin (TTM)	0.0%	15.9%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-112M	$39M
FCF (TTM)	$-88M	$33M
EPS (TTM)	-$2.62	$0.16
ROE (TTM)	-9567.0%	53.0%
ROA (TTM)	-10788.0%	20.8%
ROIC (TTM)	-9567.0%	50.2%
Financial Health
Cash	$155M	$48M
Debt	$0	$5M
Net Cash/Debt	$155M	$43M
Current Ratio (TTM)	5.05x	1.60x
Quick Ratio (TTM)	5.00x	1.52x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	1.23
52W Performance	-8.8%	26.5%
YTD Performance	40.5%	19.2%
% from 52W High	-53.0%	-48.6%
% from 52W Low	61.9%	42.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.31x
FCF Yield (TTM)	-78.9%	31.8%
Earnings Yield (TTM)	-100.0%	36.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	214.8
EV/GP/RG	N/A	N/A
Ticker research	View IMUX research	View VXRT research

Valuation

P/E Ratio

VXRT

2.73x

P/S Ratio

IMUX

0.00x

VXRT

0.43x

EV/FCF

IMUX

0.49x

VXRT

1.85x

Growth & revenue

Revenue Growth TTM

VXRT

201.1%

Forward Revenue Growth

IMUX

650.4%

VXRT

-98.8%

Profitability & performance

Gross Margin

VXRT

100.0%

IMUX

0.0%

ROE

VXRT

53.0%

IMUX

-9567.0%

FCF Yield %

VXRT

31.8%

IMUX

-78.9%

52-Week Performance

VXRT

26.5%

IMUX

-8.8%

Detailed metrics comparison

IMUX

Immunic Inc

VXRT

Vaxart Inc

Market Cap

IMUX$112M

VXRT$105M

Enterprise Value

IMUX$-44M

VXRT$62M

Price

IMUX$8.19

VXRT$0.43

P/E Ratio

IMUXN/A

VXRT2.73x

P/S Ratio

IMUX0.00x

VXRT0.43x

EV/Sales

IMUX0.00x

VXRT0.25x

EV/EBITDA

IMUX0.00x

VXRT1.01x

P/B Ratio

IMUX0.85x

VXRT1.27x

P/FCF Ratio

IMUXN/A

VXRT3.15x

EV/FCF

IMUX0.49x

VXRT1.85x

PEG Ratio

IMUXN/A

VXRTN/A

Forward P/E (NTM)

IMUXN/A

VXRTN/A

Forward P/S (NTM)

IMUXN/A

VXRTN/A

Revenue (TTM)

IMUX$0

VXRT$243M

Revenue Growth (YoY)

IMUXN/A

VXRT201.1%

Forward Rev Growth

IMUX650.4%

VXRT-98.8%

Gross Margin (TTM)

IMUX0.0%

VXRT100.0%

Operating Margin (TTM)

IMUX0.0%

VXRT16.3%

EBITDA Margin (TTM)

IMUX0.0%

VXRT18.8%

Net Margin (TTM)

IMUX0.0%

VXRT15.9%

FCF Margin (TTM)

IMUXN/A

VXRT13.7%

Net Income (TTM)

IMUX$-112M

VXRT$39M

FCF (TTM)

IMUX$-88M

VXRT$33M

EPS (TTM)

IMUX-$2.62

VXRT$0.16

ROE (TTM)

IMUX-9567.0%

VXRT53.0%

ROA (TTM)

IMUX-10788.0%

VXRT20.8%

ROIC (TTM)

IMUX-9567.0%

VXRT50.2%

Cash

IMUX$155M

VXRT$48M

Debt

IMUX$0

VXRT$5M

Net Cash/Debt

IMUX$155M

VXRT$43M

Current Ratio (TTM)

IMUX5.05x

VXRT1.60x

Quick Ratio (TTM)

IMUX5.00x

VXRT1.52x

Debt/Equity (TTM)

IMUX0.00x

VXRT0.06x

Debt/Assets (TTM)

IMUX0.0%

VXRT0.0%

Interest Coverage (TTM)

IMUXN/A

VXRTN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

VXRT0.00x

Beta

IMUX1.47

VXRT1.23

52W Performance

IMUX-8.8%

VXRT26.5%

YTD Performance

IMUX40.5%

VXRT19.2%

% from 52W High

IMUX-53.0%

VXRT-48.6%

% from 52W Low

IMUX61.9%

VXRT42.4%

Asset Turnover (TTM)

IMUX0.00x

VXRT1.31x

FCF Yield (TTM)

IMUX-78.9%

VXRT31.8%

Earnings Yield (TTM)

IMUX-100.0%

VXRT36.7%

Dividend Yield (TTM)

IMUXN/A

VXRTN/A

Rule of 40

IMUX0.0

VXRT214.8

EV/GP/RG

IMUXN/A

VXRTN/A

Ticker research

View IMUX research View VXRT research

Metric	IMUX Immunic Inc	VXRT Vaxart Inc
Market & Valuation
Market Cap	$112M	$105M
Enterprise Value	$-44M	$62M
Price	$8.19	$0.43
P/E Ratio	N/A	2.73x
P/S Ratio	0.00x	0.43x
EV/Sales	0.00x	0.25x
EV/EBITDA	0.00x	1.01x
P/B Ratio	0.85x	1.27x
P/FCF Ratio	N/A	3.15x
EV/FCF	0.49x	1.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$243M
Revenue Growth (YoY)	N/A	201.1%
Forward Rev Growth	650.4%	-98.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	16.3%
EBITDA Margin (TTM)	0.0%	18.8%
Net Margin (TTM)	0.0%	15.9%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-112M	$39M
FCF (TTM)	$-88M	$33M
EPS (TTM)	-$2.62	$0.16
ROE (TTM)	-9567.0%	53.0%
ROA (TTM)	-10788.0%	20.8%
ROIC (TTM)	-9567.0%	50.2%
Financial Health
Cash	$155M	$48M
Debt	$0	$5M
Net Cash/Debt	$155M	$43M
Current Ratio (TTM)	5.05x	1.60x
Quick Ratio (TTM)	5.00x	1.52x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	1.23
52W Performance	-8.8%	26.5%
YTD Performance	40.5%	19.2%
% from 52W High	-53.0%	-48.6%
% from 52W Low	61.9%	42.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.31x
FCF Yield (TTM)	-78.9%	31.8%
Earnings Yield (TTM)	-100.0%	36.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	214.8
EV/GP/RG	N/A	N/A
Ticker research	View IMUX research	View VXRT research